Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Folic Acid for Radiation Esophagitis in Lung Cancer
NCT05296369Unknown
- Sponsor
- Guizhou Medical University
- Start
- Mar 2022
- Primary completion
- May 2023
- Modality
- Orthosteric Ligands, Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
Randomised trial of folic acid in radiation esophagitis (2 arms), sponsored by Guizhou Medical University. Primary endpoint: Progression-free survival at 12 months. Status: unknown.
02
Drugs
folic acid
03
Conditions
radiation esophagitis
Beyond the preview
Go deeper on NCT05296369.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05296369.